Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Rallybio Corporation stock

Learn how to easily invest in Rallybio Corporation stock.

Rallybio Corporation is a biotechnology business based in the US. Rallybio Corporation shares (RLYB) are listed on the NASDAQ and all prices are listed in US Dollars. Rallybio Corporation employs 44 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Rallybio Corporation stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – RLYB. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Rallybio Corporation stock price (NASDAQ: RLYB)

Use our graph to track the performance of RLYB stocks over time.

Rallybio Corporation shares at a glance

Information last updated 2023-02-02.
Latest market close$6.81
52-week range$4.54 - $15.89
50-day moving average $6.10
200-day moving average $9.09
Wall St. target price$25.40
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.75

Buy Rallybio Corporation stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Rallybio Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Rallybio Corporation price performance over time

Historical closes compared with the close of $6.81 from 2023-02-07

1 week (2023-02-02) 0.44%
1 month (2023-01-09) 15.62%
3 months (2022-11-09) -15.19%
6 months (2022-08-09) -33.82%
1 year (2022-02-09) -52.28%
2 years (2021-02-05) N/A
3 years (2020-02-05) N/A
5 years (2018-02-05) N/A

Rallybio Corporation financials

Gross profit TTM $0
Return on assets TTM -23.37%
Return on equity TTM -39.49%
Profit margin 0%
Book value $4.11
Market capitalisation $256.5 million

TTM: trailing 12 months

Rallybio Corporation share dividends

We're not expecting Rallybio Corporation to pay a dividend over the next 12 months.

You may also wish to consider:

Rallybio Corporation overview

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; and RLYB116, a subcutaneously administered inhibitor of C5 for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut. .

Frequently asked questions

What percentage of Rallybio Corporation is owned by insiders or institutions?
Currently 6.476% of Rallybio Corporation shares are held by insiders and 78.61% by institutions.
How many people work for Rallybio Corporation?
Latest data suggests 44 work at Rallybio Corporation.
When does the fiscal year end for Rallybio Corporation?
Rallybio Corporation's fiscal year ends in December.
Where is Rallybio Corporation based?
Rallybio Corporation's address is: 234 Church Street, New Haven, CT, United States, 06510
What is Rallybio Corporation's ISIN number?
Rallybio Corporation's international securities identification number is: US75120L1008

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site